(Reuters) -Danish drugmaker Novo Nordisk has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications, Bloomberg News reported on Thursday citing people with knowledge of the matter.
(Reporting by Sriparna Roy in Bengaluru; Editing by Mrigank Dhaniwala)
